Global Cell Lysis Market 2017-2021


◆タイトル:Global Cell Lysis Market 2017-2021
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆資料形式:PDF / 英語
Single User(1名利用)USD3,500 ⇒換算¥367,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥420,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥525,000見積依頼/購入/質問フォーム
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。





About Cell Lysis
Cells are considered as the basic unit of life. The study of different cell structures is called cell biology. The understanding of cells and their components is crucial as several patterns can be observed and several compounds can be discovered. This could contribute to the discovery of new treatments or advancements of existing treatments. Cell biology can also help increase target population and enhance the mechanism of action (MOA) to reduce treatment time.

Technavio’s analysts forecast the global cell lysis market to grow at a CAGR of 7.54% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global cell lysis market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of instruments and consumables that are used for cell lysis.

The market is divided into the following segments based on geography:
• Americas

Technavio’s report, Global Cell Lysis Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Bio-Rad Laboratories
• Beckman Coulter
• Merck Millipore
• Thermo Fisher Scientific

[Other prominent vendors]
• Becton, Dickinson and Company
• Cell Signaling Technology
• F. Hoffmann–La Roche
• Miltenyi Biotec
• Omni International
• Qiagen
• Qsonica

[Market driver]
• Expanding biotechnology industry
• For a full, detailed list, view our report

[Market challenge]
• Excessive cost of cell-based research
• For a full, detailed list, view our report

[Market trend]
• Emergence of unique methods of cell disruption
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.


Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Overview

PART 05: Market landscape
• Overview
• Market size and forecast
• Five forces analysis

PART 06: Segmentation by end-user
• Overview
• Research laboratories and institutions
• Biotechnology and pharmaceutical companies
• Others

PART 07: Segmentation by geography
• Overview
• Americas

PART 08: Decision framework

PART 09: Drivers and challenges
• Market drivers
• Market challenges

PART 10: Market trends
• Increasing use of reagents for cell disruption
• Emergence of unique methods of cell disruption
• Emerging economies offering growth opportunities

PART 11: Vendor landscape
• Competitive scenario
• Investment opportunity

PART 12: Key vendor analysis
• Bio-Rad Laboratories
• Beckman Coulter
• Merck Millipore
• Thermo Fisher Scientific
• Other prominent vendors

PART 13: Appendix
• List of abbreviations

[List of Exhibits]
Exhibit 01: Cell lysis: Physical disruption methods
Exhibit 02: Global cell lysis market: Overview
Exhibit 03: Global cell lysis market 2016-2021 ($ millions)
Exhibit 04: Global cell lysis market: Segmentation by product type 2016 and 2021 (% share)
Exhibit 05: Global cell lysis market: Factors and their impact
Exhibit 06: Five forces analysis
Exhibit 07: Global cell lysis market: Segmentation by end-user 2016 and 2021 (% share)
Exhibit 08: Global cell lysis market: Overview of segmentation by end-user
Exhibit 09: Global cell lysis market by research laboratories and institutions 2016-2021 ($ millions)
Exhibit 10: Global cell lysis market by biotechnology and pharmaceutical companies 2016-2021 ($ millions)
Exhibit 11: Global cell lysis market by others 2016-2021 ($ millions)
Exhibit 12: Global cell lysis market: Segmentation by geography 2016 and 2021 (% share)
Exhibit 13: Global cell lysis market: Overview of segmentation by geography
Exhibit 14: Cell lysis market in Americas 2016-2021 ($ millions)
Exhibit 15: Cell lysis market in EMEA 2016-2021 ($ millions)
Exhibit 16: Cell lysis market in APAC 2016-2021 ($ millions)
Exhibit 17: Biopharmaceutical market: Factors that drive growth
Exhibit 18: Traditional methods of cell lysis: Challenges
Exhibit 19: Advantages of reagents over traditional methods
Exhibit 20: R&D spending of countries 2014
Exhibit 21: Strategic success factors for various companies
Exhibit 22: Investment opportunity mapping
Exhibit 23: Bio-Rad Laboratories: Overview
Exhibit 24: Bio-Rad Laboratories: Strength analysis
Exhibit 25: Bio-Rad Laboratories: Strategy assessment
Exhibit 26: Bio-Rad Laboratories: Opportunity assessment
Exhibit 27: Beckman Coulter: Overview
Exhibit 28: Beckman Coulter: Strength analysis
Exhibit 29: Beckman Coulter: Strategy assessment
Exhibit 30: Beckman Coulter: Opportunity assessment
Exhibit 31: Merck Millipore: Overview
Exhibit 32: Merck Millipore: Strength analysis
Exhibit 33: Merck Millipore: Strategy assessment
Exhibit 34: Merck Millipore: Opportunity assessment
Exhibit 35: Thermo Fisher Scientific: Overview
Exhibit 36: Thermo Fisher Scientific: Strength analysis
Exhibit 37: Thermo Fisher Scientific: Strategy assessment
Exhibit 38: Thermo Fisher Scientific: Opportunity assessment


Bio-Rad Laboratories, Beckman Coulter, Merck Millipore, Thermo Fisher Scientific, Becton, Dickinson and Company, Cell Signaling Technology, F. Hoffmann–La Roche, Miltenyi Biotec, Omni International, Qiagen, and Qsonica.